Idaho Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Pfizer, Inc. (NY: PFE)
29.04 USD  -0.07 (-0.24%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Pfizer, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Earnings Preview: Media Giants in the Spotlight
April 26, 2013
We're heading into the end of the heavy period of earnings season. Next week more than a quarter of the S&P 500 is set to report, including big names in media. Read More
category tvcodes/tvnn , tvcodes/tvearn , Merck & Co Inc , and 40 more.
from CNBC.com News
The Markets Now: Stocks Pull Back After GDP, Consumer Sentiment Reports
April 26, 2013
Plus, George Soros revealed that he owns a stake in JC Penney. Read More
category AMZN , AAPL , PFE , and 1 more.
from Minyanville Headlines
UPDATE 3-AbbVie delivers on strong growth of Humira arthritis drug
April 26, 2013
April 26 (Reuters) - AbbVie Inc's quarterly profit rose 10 percent on surging sales of its Humira treatment for rheumatoid arthritis, and the company said it plans to launch several potentially... Read More
category companyNews
from Reuters: Company News
Cardio Drugs Can Weigh On Pfizer’s Results
April 26, 2013
category Pharmaceuticals
from Trefis
Humira Still Abbvie Story With Pipeline Chapter Ahead
April 26, 2013
In its first quarter as a standalone pharmaceutical company, AbbVie (ABBV) delivered as promised robust growth from its Humira biologic for myriad autoimmune diseases while Wall Street awaits some key... Read More
category NYSE:ABBV , NYSE:PFE , NYSE:ABT , and 1 more.
from Forbes Real Time
StreetInsider.com Pre-Open Movers 4/26: (AVNR) (DHI) (FB) Higher; (PKI) (BIDU) (GNC) Lower (more...)
April 26, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8281876 for the full story. Read More
from StreetInsider.com News Articles
Biotech Micro Caps Offer Promise of Mighty Returns: Dick Huebner
April 26, 2013
category Pharmaceuticals , Internet
from Trefis
Market Wrap: Options on the Fritz; Yahoo! Chair Ducks Out; JCPenney Finds Hope...in Soros
April 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8280834 for the full story. Read More
from StreetInsider.com News Articles
Streetinsider.com After-Hours Movers 4/25: (SYNA) (JCP) (LOGM) Higher; (PKI) (EXPE) (AMZN) Lower (more...)
April 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8280816 for the full story. Read More
from StreetInsider.com News Articles
EU Rejection of XELJANZ Will Cost Pfizer (PFE) Millions
April 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8280814 for the full story. Read More
from StreetInsider.com News Articles
UPDATE 1-Pfizer arthritis drug rejected by European regulators
April 25, 2013
April 25 (Reuters) - European regulators declined to approve marketing of Pfizer Inc's new rheumatoid arthritis treatment Xeljanz, citing the risks of the drug compared with its potential benefit, the... Read More
category companyNews
from Reuters: Company News
40% Of The Largest U.S. Companies Founded by Immigrants or Their Children
April 25, 2013
Here's a damned fine argument for letting more qualified immigrants into America. Immigrants were key in the founding of Proctor& Gamble in 1837, Pfizer in 1849 and U.S. Steel in 1901-- as well as more... Read More
category NASDAQ:GOOG , NYSE:PFE , NASDAQ:INTC , and 2 more.
from Forbes Real Time
Pfizer Receives CHMP Negative Opinion Regarding Marketing Authorization In Europe For Rheumatoid Arthritis Treatment XELJANZ® (tofacitinib citrate)
April 25, 2013
Pfizer Inc. (NYSE: PFE ) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion for XELJANZ® (tofacitinib... Read More
category Benzinga , News , FDA , and 1 more.
from Latest Articles from Benzinga.com
Biotech Micro Caps Offer Promise of Mighty Returns: Dick Huebner
April 25, 2013
Biotech Micro Caps Offer Promise of Mighty Returns: Dick Huebner Source: George S. Mack of The Life Sciences Report (4/25/13) http://www.thelifesciencesreport.com/pub/na/15174 Dick Huebner knows what... Read More
category MSLP , LFVN , OMBP , and 5 more.
from Bio-Wire.Com
Daily Dividend Report: DNKN, PFE, V, LMT, AFL
April 25, 2013
This morning, Dunkin' Brands (DNKN) declared its quarterly dividend of 19 cents per share, maintaining the amount paid to shareholders last quarter. Based on the current stock price, investors can... Read More
category Dividends
from Dividend Channel
UPDATE 3-Bristol-Myers Squibb sales disappoint, shares fall
April 25, 2013
April 25 (Reuters) - Bristol-Myers Squibb reported disappointing first-quarter sales, prompting a drop in shares that have risen sharply this year on enthusiasm for its lineup of promising experimental... Read More
category companyNews
from Reuters: Company News
In Moribund Cholesterol Field, A New Drug Emerges
April 25, 2013
The artery disease that leads to heart attacks and strokes is the biggest killer in the United States. But when it comes to new drugs in development, atherosclerosis is dwarfed by cancer and... Read More
category NYSE:SNY , NYSE:PFE , NASDAQ:ISIS , and 2 more.
from Forbes Real Time
Pfizer (PFE) Reports Celebrex Phase 4 Met Primary Endpoint
April 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8277592 for the full story. Read More
from StreetInsider.com News Articles
Cramer: Sellers Clobbering Stocks Recklessly?
April 24, 2013
Pockets of weakness in the market have captured Jim Cramer's attention. Is the selling really warranted? Read More
category Biotechnology , tvcodes/tvearn , tvcodes/tvearnings , and 30 more.
from CNBC.com News
These ETFs Could Benefit From Apple Dividend Growth
April 24, 2013
Following another disappointing earnings report, shares of Apple (NASDAQ: AAPL ) traded in a wide range of nearly $23 Wednesday, but to the stock's credit, it closed with just a modest loss. Perhaps... Read More
category DLN , Benzinga , SDY , and 27 more.
from Latest Articles from Benzinga.com
Brystol-Myers Squibbs Preview: Performance Of New Drugs The Key
April 24, 2013
category Pharmaceuticals , Unassigned
from Trefis
VTV, PFE, PG, WFC: Large Inflows Detected at ETF
April 24, 2013
Symbols mentioned in this story: VTV, PFE, PG, WFC Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
A Former Google Exec Aims To Power A Patient Revolution
April 24, 2013
Last week I went to TedMed, the big medical innovation summit run by Priceline founder Jay Walker. The most important presentation I saw may have come from Roni Zeiger, who for six years ending in 2012... Read More
category NASDAQ:GOOG , NYSE:PFE , NYSE:GSK , and 1 more.
from Forbes Real Time
Boehringer anti-clotting pill gains blockbuster status
April 24, 2013
INGELHEIM, Germany, April 24 (Reuters) - Boehringer Ingelheim said its anti-blood-clotting drug Pradaxa reached blockbuster status in 2012, helping the world's largest unlisted drugmaker to an 11.5... Read More
category companyNews
from Reuters: Company News
3 Spring Cleaning Ideas for Investors
April 24, 2013
 Read More
category NYSE:JNJ , NYSE:PFE , Financial Advisor Center , and 1 more.
from InvestorPlace - Latest Headlines
Watch for Shares of Pfizer (PFE) to Approach Resistance at $31.27
April 23, 2013
from Comtex SmarTrend® News Briefs
Eli Lilly Earnings Preview: EPS, Sales Growth Expected
April 23, 2013
Eli Lilly (NYSE: LLY ), which last week announced a deal to buy two imaging agents from Siemens (NYSE: SI ) that could help aid the fight against Alzheimer's, is scheduled to report its first-quarter... Read More
category Earnings , Benzinga , SI , and 11 more.
from Latest Articles from Benzinga.com
Moody's sees pick-up in pharmaceutical industry M&A in 2013
April 22, 2013
LONDON, April 23 (Reuters) - Cash-rich drug companies are likely to make more acquisitions in 2013 after a thin year for deals in 2012, ratings agency Moody's Investors Service said on Tuesday. Read More
category companyNews
from Reuters: Company News
No 'Silver Bullet' for Fixing Health Care: J&J CEO
April 22, 2013
It will take a combination of approaches to help make health care more affordable, Johnson & Johnson CEO Alex Gorsky told CNBC. Read More
category Merck & Co Inc , Maria's Market Message , Closing Bell , and 6 more.
from CNBC.com News
Big Pharma Exit: Who's Fighting the Superbugs?
April 22, 2013
Big pharma is abandoning antibiotic research at a time when fears over superbugs are growing at an alarming rate. That's left just a few smaller firms to step into the breach between these... Read More
category GlaxoSmithKline plc , Health Care/Health Care Equipment and Services/Health Care Providers and Services/Health Care Servic , Cubist Pharmaceuticals Inc , and 10 more.
from CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here